MNKD:NASDAQ
MannKind Corp
$3.75
arrow_downward
-1.06%(-0.040) 1D
Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$3.83
High
$3.85
Low
$3.73
Mkt. cap
1.21B
Avg. vol.
3.96M
Volume
0.00
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
Open
$3.83
High
$3.85
Low
$3.73
Mkt. cap
1.21B
Avg. vol.
3.96M
Volume
0.00
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
Simply Wall Street
·
2 days ago
MannKind (MNKD) Stock May Be 15% Undervalued After Inhaled GLP 1 Deal
Investing.com
·
2 days ago
Cantor Fitzgerald reiterates Overweight on MannKind stock at $8
Investing.com
·
2 days ago
Cantor Fitzgerald reiterates Overweight rating on MannKind stock
GuruFocus
·
2 days ago
MNKD Reiterates by Cantor Fitzgerald -- Price Target Maintained at $6.50
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com